CPI(M) turns the heat on Keralam govt. over SMA drug controversy
CPI(M) State secretary M.V. Govindan has criticized the Kerala government over the administration of drugs meant for clinical trials to children suffering from spinal muscular atrophy. He accused the government of prioritizing privatization and failing to provide transparency regarding drug safety and quality.
Why it matters
The controversy raises significant ethical questions regarding clinical trial protocols and government accountability in the public health sector.
CPI(M) turns the heat on Keralam govt. over SMA drug controversy left M.V. Govindan. The Hindu https://th-i.thgim.com/public/incoming/xhqnha/article71617237.ece/alternates/FREE_1200/Opposition-sharGR6GBHB69.3.jpg.jpg K Ragesh CPI(M) State secretary M.V. Govindan addressing a press conference in Kozhikode on Monday. CPI(M) State secretary M.V. Govindan says the government’s agenda of ushering in privatisation is being followed even in the health sector THIRUVANANTHAPURAM Accusing the Congress-led United Democratic Front (UDF) government of following the Bharatiya Janata Party (BJP)’s corporate Hindutva policies by the book, Communist Party of India (Marxist) [CPI(M)] State secretary M.V. Govindan has said that the government’s agenda of ushering in privatisation is being followed even in the health sector. Speaking at a press conference here on Friday after the CPI(M) State committee meeting, Mr. Govindan said that Health Minister K.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in